Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study Journal Articles Refereed uri icon

Overview

Published in

  • Pharmacogenetics and Genomics

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1097/FPC.0000000000000253

Additional Document Info

Parent Title

  • PHARMACOGENETICS AND GENOMICS

Volume

  • 27

Issue

  • 1

Publisher

  • Lippincott Williams & Wilkins